Dr Lal PathLabs : Business Responsibility & Sustainability Report (BRSR)

Annexure-9

Business Responsibility &

Sustainability Report

SECTION A: GENERAL DISCLOSURES

1. Details of the listed entity

1. Corporate Identity Number (CIN) of the Listed Entity: L74899DL1995PLC065388
2. Name of the Listed Entity: Dr. Lal PathLabs Limited
3. Year of incorporation: 1995
4. Registered office address: Block E, Sector-18, Rohini, New Delhi-110085
5. Corporate address: 12th Floor, Tower B, SAS Tower, Medicity, Sector-38,Gurugram-122001
6. E-mail: [e-mail]

7. Telephone: [phone]

8 Website: www.lalpathlabs.com

1. Financial year for which reporting is being done: FY 2021-22
2. Name of the Stock Exchange(s) where shares are listed: National Stock Exchange of India Limited and
   BSE Limited
3. Paid-upCapital: ` 83,34,48,770 divided into 8,33,44,877 Equity Shares of ` 10/- each

12 Name and contact details (telephone, email address) of the person who may be contacted in case of any queries on the BRSR report: Mr. Manoj Garg, Chief Human Resource Officer, Tel: + 91-124-3016-500,

Email: [e-mail]

1. Reporting boundary - Are the disclosures under this report made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together): Standalone basis

II. Products/services

1. Details of business activities (accounting for 90% of the turnover):

S. No.	Description of Main Activity	Description of	% of Turnover of
		Business Activity	the entity
1.	Other Human Health Activities	Activities of Independent	100%
		Diagnostics/Pathological
		Laboratories

15. Products/Services sold by the entity (accounting for 90% of the entity's Turnover):

S. No.	Product/Service	NIC Code	% of total Turnover
			contributed
1.	Diagnostic and related healthcare	869	100%
	tests and services

72 Annual Report 2021 - 22

Statutory Reports

III. Operations

16. Number of locations where plants and/or operations/offices of the entity are situated:

Location	Number of plants	Number of	Total
		offices / Labs

National

International

Not Applicable as the Company provides Diagnostic Services in the area of Pathology and Radiology

195195*

22

	* Standalone Number
17. Markets served by the entity:
	a. Number of locations
		Locations	Number
		National (No. of States)	The Company has Laboratories in 25 States and
				5 Union Territories.
		International (No. of Countries)	India, Nepal and Bangladesh.
				Besides the above, the Company also receives samples
				from International Locations like Bhutan, Sri Lanka,
				Myanmar, Malaysia, Cambodia, Maldives, UAE, Saudi
				Arabia, Bahrain, Qatar, Kuwait, Ethiopia, Tanzania,
				Uganda, Malawi, Zambia, Nigeria, Ghana, Sierra Leone
				& Mauritius for testing in India.

1. What is the contribution of exports as a percentage of the total turnover of the entity?
   1% (one percent)
2. A brief on types of customers:
   The Company's customers include individual patients, hospitals, other healthcare providers and corporate customers.

IV. Employees

18. Details as at the end of Financial Year:

a. Employees and workers (including differently abled):

S.	Particulars	Total	Male	Female
No.		(A)	No. (B)	% (B / A)	No. (C)	% (C / A)
		EMPLOYEES
1.	Permanent (D)	1,289			1,042	80.84	247	19.16
2.	Other than	120			64	53.33	56	46.67
	Permanent (E)
3.	Total employees (D + E)	1,409			1,106	78.5	303	21.50
			WORKERS*
4.	Permanent (F)	2,821			2,163	76.67	658	23.33
5.	Other than	11			5	45.45	6	54.55
	Permanent (G)
6.	Total workers (F + G)	2,832			2,168	76.55	664	23.45

* Based on an internal assessment, we have categorised employees below a certain grade as Workers.

Note: Workers and Employees includes all people who were on the payrolls of the Company as of March 31, 2022, except 11, who were on Lal PathLabs Foundation payroll.

Dr. Lal PathLabs Limited 73

1. Differently abled Employees and workers:

		S.	Particulars				Total		Male							Female
		No						(A)			No. (B)	% (B / A)	No. (C)	% (C / A)
							DIFFERENTLY ABLED EMPLOYEES
1.	Permanent (D)			-		-		-		-		-
2.	Other than			-		-		-		-		-
			Permanent (E)
3.	Total differently abled	-		-		-		-		-
			employees (D + E)
								DIFFERENTLY ABLED WORKERS
4.	Permanent (F)			12		12		100		-		-
5.	Other than			-		-		-		-		-
			permanent (G)
6.	Total differently abled	12		12		100		-		-
			workers (F + G)
19. Participation/Inclusion/Representation of women
								Total					No. and percentage of Females
								(A)								No. (B)				% (B / A)
	Board of Directors			10										3				30
	Key Management Personnel	6										1				17
20. Turnover rate for permanent employees and workers
(Disclose trends for the past 3 years)
											FY 2020-21						FY 2019-20
					FY 2021-22
				(Turnover rate in current		(Turnover rate in previous	(Turnover rate in the year
					FY)						FY)					prior to the previous FY)
				Male	Female			Total		Male		Female		Total		Male		Female		Total
	Permanent	25.17	21.69		24.53		16.90		17.05		16.93		23.23		14.62		21.82
	Employees
	Permanent	12.49	15.56		13.21		10.95		12.56		11.33		10.97		14.61		11.84
	Workers

1. Holding, Subsidiary and Associate Companies (including joint ventures)

21. (a) Names of holding / subsidiary / associate companies / joint ventures

S.	Name of the holding/	Indicate whether	% of shares held	Does the entity
No.	subsidiary/ associate	holding/	by listed entity	indicated at column
	companies/ joint	Subsidiary/		A, participate in the
	ventures (A)	Associate/ Joint		Business Responsibility
		Venture		initiatives of the listed
				entity? (Yes/No)
1	Paliwal Diagnostics Private	Subsidiary	80	No
	Limited
2	Paliwal Medicare Private	Subsidiary	80	No
	Limited
3	APL Institute of Clinical	Subsidiary	100	No
	Laboratory & Research Private
	Limited

74 Annual Report 2021 - 22

				Statutory Reports
S.	Name of the holding/	Indicate whether	% of shares held	Does the entity
No.	subsidiary/ associate	holding/	by listed entity	indicated at column
	companies/ joint	Subsidiary/		A, participate in the
	ventures (A)	Associate/ Joint		Business Responsibility
		Venture		initiatives of the listed
				entity? (Yes/No)
4	Dr. Lal Ventures Private	Subsidiary	100	No
	Limited
5	PathLabs Unifiers Private	Subsidiary	100	No
	Limited
6	Centrapath Labs Private	Step down	70	No
	Limited	Subsidiary
7	APRL PathLabs Private	Step down	70	No
	Limited	Subsidiary
8	Chanre Laboratory Private	Step down	70	No
	Limited	Subsidiary
9	Dr. Lal PathLabs Nepal	Subsidiary	100	No
	Private Limited
10	Dr. Lal Path Labs	Subsidiary	71.83	No
	Bangladesh Private Limited
11	Dr. Lal PathLabs Kenya	Subsidiary	100	No
	Private Limited
12	Suburban Diagnostics	Subsidiary	100	No
	(India) Private Limited

VI. CSR Details

22. (i) Whether CSR is applicable as per section 135 of Companies Act, 2013: Yes

1. Turnover : ` 18,727.06 Millions
2. Net worth : ` 16,502.65 Million

Dr. Lal PathLabs Limited 75

22 - 2021 Report Annual 76

VII. Transparency and Disclosures Compliances

23. Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible Business Conduct:

Stakeholder

Grievance Redressal

FY 2021-22

FY 2020-21

group from

Mechanism in Place (Yes/No)

Current Financial Year

Previous Financial Year

whom

(If Yes, then provide web-link

Number of

Number of

complaint is

for grievance redress policy)

Number of

complaints

Remarks

Number of

complaints

Remarks

received

complaints

pending

complaints

pending

filed during

resolution at

filed during

resolution at

the year

close of the

the year

close of the

year

year

Communities

No

There weren't any complaints / grievances received from any specific community.

Investors

Yes.

There were no complaints that were received.

(other

Investors can contact the

than

officials

mentioned in the link

shareholders)

below https://www.lalpathlabs.

com/investor/investor-contact.

aspx

Shareholders

Yes

187

5

5 (Five)

438

-

6 (Six)

Shareholders, for any of their

Shareholders

Shareholders

grievances can reach out to the

Complaints were

Complaints were

Company Secretary at

unresolved as of

carry forward of

https://www.lalpathlabs.com/

March 31, 2022.

previous years

Those 5 have

which were also

investor/investor-contact.aspx

been resolved as

resolved during

of date.

the current year.

Employees

The Company does have a

There weren't any complaints / grievances received.

and workers

specific internal Grievance

Redressal Policy in place.

Customers*

The Company does not have

79,274

237

The unresolved

54,177

-

a specific

Grievance Redressal

complaints as of

Policy in place.

March 31, 2022

However, there is a dedicated

have all been

helpline number (011-

subsequentlly

49885050) and email id

resolved.

customer.care@lalpathlabs.

com which address and

resolves all customer

grievances.

Value Chain

No

There were no complaints/grievances received from the Value Chain Partners except some

Partners

outstanding dues related clarifications, which were properly addressed and resolved.

Other (please

-

-

-

-

specify)

* The increase in Customer cases from the previous year is majorily attributable to an unparallel rise in Covid-19 cases